Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5171147

COc1ccc(C[C@H](NC(=O)[C@@H]2CCCCN2S(=O)(=O)c2cccc(F)c2)C(=O)O)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KCNQ1 P51787 6/20 0.57
ITGB1 P05556 7/20 0.54
ITGA4 P13612 5/20 0.54
ITGB7 P26010 3/20 0.54
ITGA5 P08648 2/20 0.53
ITGAV P06756 1/20 0.49
HCRTR1 O43613 2/20 0.48
HCRTR2 O43614 2/20 0.48
MMP1 P03956 1/20 0.48
MMP3 P08254 1/20 0.48
MMP7 P09237 1/20 0.48
MMP13 P45452 1/20 0.48
FKBP1A P62942 2/20 0.47
LMNA P02545 1/20 0.47
TSHR P16473 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
FKBP4 Q02790 1/20 0.47
FKBP5 Q13451 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5171521 0.97 KCNQ1 (0.60) KCNQ1ITGB1ITGA4ITGB7ITGA5
SCHEMBL630691 0.97 KCNQ1 (0.60) KCNQ1ITGB1ITGA4ITGB7ITGA5
SCHEMBL630690 0.97 KCNQ1 (0.60) KCNQ1ITGB1ITGA4ITGB7ITGA5
SCHEMBL5171150 0.90 KCNQ1 (0.55) KCNQ1ITGB1ITGA4ITGB7ITGA5
SCHEMBL629837 0.90 KCNQ1 (0.62) KCNQ1ITGB1ITGA4ITGB7ITGA5
SCHEMBL629838 0.90 KCNQ1 (0.62) KCNQ1ITGB1ITGA4ITGB7ITGA5
SCHEMBL5173103 0.90 KCNQ1 (0.62) KCNQ1ITGB1ITGA4ITGB7ITGA5
SCHEMBL630250 0.89 ITGB1 (0.55) KCNQ1ITGB1ITGA4ITGB7ITGA5
SCHEMBL630254 0.89 ITGB1 (0.55) KCNQ1ITGB1ITGA4ITGB7ITGA5
SCHEMBL630255 0.89 ITGB1 (0.55) KCNQ1ITGB1ITGA4ITGB7ITGA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1778637-A2 FKBP BINDING COMPOSITION AND PHARMACEUTICAL USE THEREOF Aventis Pharmaceuticals, Inc. (US) 2007-05-02 EP disclosed
WO-2006012256-A2 FKBP BINDING COMPOSITION AND PHARMACEUTICAL USE THEREOF AVENTIS PHARMACEUTICALS INC. (US) 2006-02-02 WO disclosed